½ÃÀ庸°í¼­
»óǰÄÚµå
1422667

Àü±â Àڱر⠽ÃÀå : Á¦Ç°, ¿ëµµ, ÃÖÁ¾»ç¿ëÀÚº° - ¼¼°è ¿¹Ãø(2024-2032³â)

Electrical Stimulators Market-By Product (Transcutaneous Electrical Nerve, Neuromuscular Electric, Spinal Cord Stimulators, Deep Brain Stimulators), Application (Pain Management, Neuromodulation, Aesthetics), End-user-Global Forecast (2024-2032)

¹ßÇàÀÏ: | ¸®¼­Ä¡»ç: Global Market Insights Inc. | ÆäÀÌÁö Á¤º¸: ¿µ¹® 132 Pages | ¹è¼Û¾È³» : 2-3ÀÏ (¿µ¾÷ÀÏ ±âÁØ)

    
    
    




¡Ø º» »óǰÀº ¿µ¹® ÀÚ·á·Î Çѱ۰ú ¿µ¹® ¸ñÂ÷¿¡ ºÒÀÏÄ¡ÇÏ´Â ³»¿ëÀÌ ÀÖÀ» °æ¿ì ¿µ¹®À» ¿ì¼±ÇÕ´Ï´Ù. Á¤È®ÇÑ °ËÅ並 À§ÇØ ¿µ¹® ¸ñÂ÷¸¦ Âü°íÇØÁֽñ⠹ٶø´Ï´Ù.

¼¼°èÀÇ Àü±â Àڱر⠽ÃÀåÀº ÀÇ·á ±â¼úÀÇ Áö¼ÓÀû Áøº¸¿Í Çõ½ÅÀûÀÎ Àü±â ÀڱرâÀÇ °³¹ß¿¡ ±âÀÎÇÏ¿© 2024-2032³â 10.0%ÀÇ CAGRÀ» ±â·ÏÇÕ´Ï´Ù. ÀÌ·¯ÇÑ ±â¼úÀû Áøº¸¿¡ ÀÇÇØ Àü±â ÀڱرâÀÇ À¯È¿¼º°ú ¹ü¿ë¼ºÀÌ Áõ°¡Çϸç, ´Ù¾çÇÑ º´»óÀÇ Ä¡·á¿¡ ´ëÇÑ ÀÀ¿ëÀÌ È®´ëÇÕ´Ï´Ù. ÃÖ÷´Ü ±â±âÀÇ °³¹ßÀº Ä¡·á ¼Ö·ç¼Ç¿¡ ´ëÇÑ ¼ö¿äÀÇ Áõ°¡¿¡ ´ëÀÀÇÏ´Â °ÍÀ¸·Î ½ÃÀåÀÇ È®´ë¿¡ Å©°Ô ±â¿©ÇÒ °ÍÀÔ´Ï´Ù.

°¢»çµéÀº Ãֽбâ¼ú Áøº¸¸¦ µµÀÔÇϰí Çõ½ÅÀûÀÎ ±â´ÉÀ» °®Ãá Àڱر⸦ Ãâ½ÃÇÏ¸ç ¾÷°è ¼±µÎ¿¡ ¼­°Ú´Ù´Â ÀÇÁö¸¦ º¸À̰í ÀÖ½À´Ï´Ù. ¿¹¸¦ µé¾î Abbott´Â 2022³â ¸¸¼º ÅëÁõ¿ëÀ¸·Î ¼³°èµÈ ¼¼°è ÃÖ¼ÒÇü À̽ÄÇü ô¼ö ÀÚ±Ø ½Ã½ºÅÛÀ» ¹ßÇ¥Çß½À´Ï´Ù. ÀÌ ÃæÀü½Ä Àåºñ´Â ¸¸¼º ÅëÁõ °ü¸® ¹®Á¦¸¦ ÇØ°áÇÒ ¼ö ÀÖ´Â Çõ½ÅÀûÀ̰í ÄÄÆÑÆ®ÇÑ ±â¼úÀ» Á¦°øÇÕ´Ï´Ù.

Àü±â Àڱر⠻ê¾÷Àº ÃÖÁ¾»ç¿ëÀÚ, ¾ÖÇø®ÄÉÀÌ¼Ç ¹× Áö¿ª¿¡ µû¶ó ºÐ·ùµË´Ï´Ù.

ÀÓ»ó ÇöÀå¿¡¼­ Ä¡·á ¸ñÀûÀ¸·Î Àü±â Àڱر⸦ »ç¿ëÇÏ´Â »ç·Ê°¡ Áõ°¡ÇÔ¿¡ µû¶ó 2032³â±îÁö ÀÓ»ó ºÎ¹®ÀÌ »ó´çÇÑ ½ÃÀå Á¡À¯À²À» Â÷ÁöÇÒ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù. ºñħ½ÀÀû ÀÇ·á °³ÀÔ¿¡ ´ëÇÑ ÀνÄÀÌ ³ô¾ÆÁö°í ÅëÁõ °ü¸® ¹× ÀçȰ¿¡ ´ëÇÑ Àû¿ë ¹üÀ§°¡ È®´ëµÊ¿¡ µû¶ó Ŭ¸®´ÐÀº ¼ö¿ä¸¦ °ßÀÎÇÏ´Â µ¥ ¸Å¿ì Áß¿äÇÑ ¿ªÇÒÀ» Çϰí ÀÖ½À´Ï´Ù. Àü±âÀڱرâÀÇ Æí¸®¼º, È¿°ú ¹× ´Ù¿ëµµ¼ºÀº ÀÓ»ó ÇöÀå¿¡¼­ÀÇ ¹ø¿µ¿¡ ±â¿©Çϸç Ŭ¸®´Ð ºÎ¹®ÀÇ ¼ºÀåÀ» ÃËÁøÇϰí ÀÖ½À´Ï´Ù.

½Å°æ Á¶Àý ºÐ¾ßÀÇ Àü±â Àڱر⠽ÃÀå ±Ô¸ð´Â ´Ù¾çÇÑ ½Å°æ Áúȯ ¹× ¸¸¼º ÅëÁõ »óÅÂÀÇ Ä¡·á¿¡ ½Å°æ Á¶Àý ±â¼úÀÇ Àû¿ë È®´ë¿¡ ÈûÀÔ¾î 2032³â±îÁö Å« ÆøÀÇ »ó½Â¼¼¸¦ º¸ÀÏ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù. ÀÇ·á ±â¼úÀÇ Áö¼ÓÀûÀÎ ¹ßÀü°ú °í·ÉÈ­ Àα¸ Áõ°¡·Î ÀÎÇØ ½Å°æÁ¶Àý ±â±â¿¡ ´ëÇÑ ¼ö¿ä°¡ ±ÞÁõÇÒ °ÍÀÔ´Ï´Ù. ½Å°æ Á¶ÀýÀÇ È¿°ú¿Í ¹ü¿ë¼ºÀº Àü±â Àڱر⠽ÃÀå¿¡¼­ ÀÌ ºÐ¾ßÀÇ ¼ºÀå°ú ¿ìÀ§¿¡ ¸Å¿ì Áß¿äÇÑ ¿ä¼Ò·Î ÀÛ¿ëÇϰí ÀÖ½À´Ï´Ù.

À¯·´ÀÇ Àü±â Àڱر⠻ê¾÷Àº ¸¸¼º ÅëÁõ ÁúȯÀÇ ±ÞÁõ°ú ±Þ¼ÓÇÑ °í·ÉÈ­·Î ÀÎÇØ 2024-2032³â ³ôÀº CAGRÀ» º¸ÀÏ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù. ÀÌ Áö¿ªÀÇ Ã·´Ü ÀÇ·á ÀÎÇÁ¶ó¿Í ÀÇ·á ±â¼ú¿¡ ´ëÇÑ ÅõÀÚ Áõ°¡°¡ ÀÌ·¯ÇÑ ¿ìÀ§¿¡ ±â¿©ÇÒ °ÍÀ¸·Î º¸ÀÔ´Ï´Ù. À¯¸®ÇÑ »óȯ Á¤Ã¥°ú ºñħ½ÀÀû Ä¡·á °³ÀÔ¿¡ ´ëÇÑ °­Á¶°¡ Áõ°¡ÇÏ¸é ½ÃÀå ¼ºÀåÀ» ´õ¿í ÃËÁøÇÒ °ÍÀÔ´Ï´Ù. ¿¬±¸°³¹ß¿¡ ÁýÁßÇϰí ÀÖ´Â À¯·´Àº ½ÃÀå ¼ºÀå¿¡ Áß¿äÇÑ ¿ªÇÒÀ» ´ã´çÇϰí ÀÖ½À´Ï´Ù.

¸ñÂ÷

Á¦1Àå Á¶»ç ¹æ¹ý°ú Á¶»ç ¹üÀ§

Á¦2Àå ÁÖ¿ä ¿ä¾à

Á¦3Àå Àü±â Àڱر⠻ê¾÷ ÀλçÀÌÆ®

  • ¿¡ÄڽýºÅÛ ºÐ¼®
  • ¾÷°è¿¡ ´ëÇÑ ¿µÇâ¿äÀÎ
    • ÃËÁø¿äÀÎ
      • ½Å°æº¯¼ºÁúȯÀÇ À¯º´·ü Áõ°¡
      • ÅëÁõ °ü¸®¾àÀÇ ´ëüǰ¿¡ ´ëÇÑ ³ôÀº ¼ö¿ä
      • ÁÂ½Ä »ýȰ¹æ½ÄÀÇ Áõ°¡¿Í º¸´Ù °£´ÜÇÑ ±ÙÀ° Á¶Á¤¹ý¿¡ ´ëÇÑ ¼ö¿ä
      • Àü±â ÀڱرâÀÇ ±â¼úÀû Áøº¸
    • ¾÷°èÀÇ ÀáÀçÀû ¸®½ºÅ© & °úÁ¦
      • Àڱر⿡ ´ëÇÑ ¾ö°ÝÇÑ ±ÔÁ¦ ÇÁ·Î¼¼½º
      • ÀåºñÀÇ º¹À⼺°ú Æ®·¹ÀÌ´×
  • ¼ºÀå °¡´É¼º ºÐ¼®
  • ±ÔÁ¦ ½Ã³ª¸®¿À
    • ¹Ì±¹
    • À¯·´
  • PorterÀÇ »ê¾÷ ºÐ¼®
  • PESTEL ºÐ¼®

Á¦4Àå °æÀï ±¸µµ

  • ¼­·Ð
    • Medtronic plc
    • Boston scientific corporation
    • Abbott laboratories
  • ±â¾÷ Á¡À¯À² ºÐ¼®
  • ÁÖ¿ä ½ÃÀå ±â¾÷ÀÇ °æÀï ºÐ¼®
  • °æÀï Æ÷Áö¼Å´× ¸ÅÆ®¸¯½º
  • Àü·« Àü¸Á ¸ÅÆ®¸¯½º

Á¦5Àå Àü±â Àڱر⠽ÃÀå ±Ô¸ð¡¤¿¹Ãø : Á¦Ç°º°, 2018-2032³â

  • ÁÖ¿ä µ¿Çâ : Á¦Ç°º°
  • °æÇÇ Àü±â ½Å°æÀڱرâ
  • ½Å°æ±Ù Àü±â Àڱرâ
  • ³ú½ÉºÎ ÀÚ±Ø ±â±â
  • ô¼ö Àڱرâ
  • ±âŸ Á¦Ç°

Á¦6Àå Àü±â Àڱر⠽ÃÀå ±Ô¸ð¡¤¿¹Ãø : ¿ëµµº°, 2018-2032³â

  • ÁÖ¿ä µ¿Çâ : ¿ëµµº°
  • ¹°¸®Ä¡·á/ÅëÁõ °ü¸®
  • ¹Ì¿ë
  • ½Å°æÁ¶Àý

Á¦7Àå Àü±â Àڱر⠽ÃÀå ±Ô¸ð¡¤¿¹Ãø : ÃÖÁ¾»ç¿ëÀÚº°, 2018-2032³â

  • ÁÖ¿ä µ¿Çâ : ÃÖÁ¾»ç¿ëÀÚº°
  • º´¿ø
  • Áø·á¼Ò
  • ÀçÅÃÀÇ·á
  • ±âŸ ÃÖÁ¾»ç¿ëÀÚ

Á¦8Àå Àü±â Àڱر⠽ÃÀå ±Ô¸ð¡¤¿¹Ãø : Áö¿ªº°, 2018-2032³â

  • ÁÖ¿ä µ¿Çâ : Áö¿ªº°
  • ºÏ¹Ì
    • ¹Ì±¹
    • ij³ª´Ù
  • À¯·´
    • µ¶ÀÏ
    • ¿µ±¹
    • ÇÁ¶û½º
    • ÀÌÅ»¸®¾Æ
    • ½ºÆäÀÎ
    • ±âŸ À¯·´
  • ¾Æ½Ã¾ÆÅÂÆò¾ç
    • Áß±¹
    • ÀϺ»
    • Àεµ
    • È£ÁÖ
    • Çѱ¹
    • ±âŸ ¾Æ½Ã¾ÆÅÂÆò¾ç
  • ¶óƾ¾Æ¸Þ¸®Ä«
    • ºê¶óÁú
    • ¸ß½ÃÄÚ
    • ¾Æ¸£ÇîÆ¼³ª
    • ±âŸ ¶óƾ¾Æ¸Þ¸®Ä«
  • Áßµ¿ ¹× ¾ÆÇÁ¸®Ä«
    • »ç¿ìµð¾Æ¶óºñ¾Æ
    • ³²¾ÆÇÁ¸®Ä«°øÈ­±¹
    • ¾Æ¶ø¿¡¹Ì¸®Æ®
    • ±âŸ Áßµ¿ ¹× ¾ÆÇÁ¸®Ä«

Á¦9Àå ±â¾÷ °³¿ä

  • Medtronic plc
  • Boston Scientific Corporation
  • Abbott Laboratories
  • BTL Corporate
  • Zynex, Inc.
  • HMS Medical Systems
  • OMRON Corporation
  • BioMedical Life Systems
  • HASOMED GmbH
  • Saluda Medical Pty Ltd
KSA 24.02.19

Global Electrical Stimulators Market will register a 10.0% CAGR from 2024 to 2032, attributed to continuous advancements in medical technology and the development of innovative electrical stimulators. These technological strides enhance the effectiveness and versatility of electrical stimulators, expanding their applications in treating various medical conditions. The development of state-of-the-art devices meets the increasing demand for therapeutic solutions and will significantly contribute to the market's expansion.

Companies are embracing the latest technological advancements and unveiling stimulators with innovative features, showcasing their commitment to staying at the forefront of the industry. For instance, in 2022, Abbott introduced the world's smallest implantable spinal cord stimulation system designed for chronic pain. This rechargeable device offers innovative and compact technology to address the challenges of chronic pain management.

The electrical stimulators industry is classified based on end-user, application, and region.

The clinics segment will capture a remarkable market share by 2032 due to the increasing adoption of electrical stimulators for therapeutic purposes in clinical settings. With growing awareness of non-invasive medical interventions and an expanding range of applications in pain management and rehabilitation, clinics play a pivotal role in driving demand. The convenience, efficacy, and versatility of electrical stimulators contribute to their prominence in clinical settings, propelling the clinics segment forward.

The electrical stimulators market size from the neuromodulation segment will witness a substantial upswing by 2032, fueled by the expanding applications of neuromodulation techniques in treating various neurological disorders and chronic pain conditions. With continuous advancements in medical technology and a growing aging population, the demand for neuromodulation devices will surge. The efficacy and versatility of neuromodulation make it a pivotal contributor to the growth and dominance of this segment in the electrical stimulators market.

Europe electrical stimulators industry will demonstrate a significant CAGR from 2024 to 2032, driven by a surge in chronic pain conditions and a rapidly aging population. The region's advanced healthcare infrastructure, coupled with increasing investments in medical technology, will contribute to this dominance. Favorable reimbursement policies and a growing emphasis on non-invasive therapeutic interventions will further bolster market growth. With a robust focus on research and development, Europe will be positioned as a key contributor to shaping market growth.

Table of Contents

Chapter 1 Methodology & Scope

  • 1.1 Market scope & definition
  • 1.2 Base estimates & workings
  • 1.3 Forecast calculations
  • 1.4 Data sources
    • 1.4.1 Primary
    • 1.4.2 Secondary
      • 1.4.2.1 Paid sources
      • 1.4.2.2 Unpaid sources

Chapter 2 Executive Summary

  • 2.1 Global electrical stimulators market 360 degree synopsis, 2018 - 2032
    • 2.1.1 Regional trends
    • 2.1.2 Product trends
    • 2.1.3 Application trends
    • 2.1.4 End-use trends

Chapter 3 Electrical Stimulators Industry Insights

  • 3.1 Industry ecosystem analysis
  • 3.2 Industry impact forces
    • 3.2.1 Growth drivers
      • 3.2.1.1 Increasing prevalence of neuro-degenerative disorder
      • 3.2.1.2 High demand for alternatives to pain management medicines
      • 3.2.1.3 Increasing sedentary lifestyle and demand for easier muscle toning methods
      • 3.2.1.4 Technological advancements in electrical stimulators
    • 3.2.2 Industry pitfalls & challenges
      • 3.2.2.1 Stringent regulatory process for stimulation devices
      • 3.2.2.2 Device complexity and training
  • 3.3 Growth potential analysis
    • 3.3.1 By product
    • 3.3.2 By application
    • 3.3.3 By end-use
  • 3.4 Regulatory scenario
    • 3.4.1 U.S.
    • 3.4.2 Europe
  • 3.5 Porter's analysis
  • 3.6 PESTEL analysis

Chapter 4 Competitive Landscape, 2023

  • 4.1 Introduction
    • 4.1.1 Medtronic plc
    • 4.1.2 Boston scientific corporation
    • 4.1.3 Abbott laboratories
  • 4.2 Company market share analysis, 2023
  • 4.3 Competitive analysis of major market players, 2023
  • 4.4 Competitive positioning matrix, 2023
  • 4.5 Strategic outlook matrix, 2023

Chapter 5 Electrical Stimulators Market Size and Forecast, By Product, 2018-2032 (USD Million)

  • 5.1 Key trends, by product
  • 5.2 Transcutaneous electrical nerve stimulator
  • 5.3 Neuromuscular electric stimulator
  • 5.4 Deep brain stimulation devices
  • 5.5 Spinal cord stimulator
  • 5.6 Other products

Chapter 6 Electrical Stimulators Market Size and Forecast, By Application, 2018-2032 (USD Million)

  • 6.1 Key trends, by application
  • 6.2 Physiotherapy /Pain management
  • 6.3 Aesthetics
  • 6.4 Neuromodulation

Chapter 7 Electrical Stimulators Market Size and Forecast, By End-Use, 2018-2032 (USD Million)

  • 7.1 Key trends, by end-use
  • 7.2 Hospitals
  • 7.3 Clinics
  • 7.4 Home care
  • 7.5 Other end-users

Chapter 8 Electrical Stimulators Market Size and Forecast, By Region, 2018-2032 (USD Million)

  • 8.1 Key trends, by region
  • 8.2 North America
    • 8.2.1 U.S.
    • 8.2.2 Canada
  • 8.3 Europe
    • 8.3.1 Germany
    • 8.3.2 UK
    • 8.3.3 France
    • 8.3.4 Italy
    • 8.3.5 Spain
    • 8.3.6 Rest of Europe
  • 8.4 Asia Pacific
    • 8.4.1 China
    • 8.4.2 Japan
    • 8.4.3 India
    • 8.4.4 Australia
    • 8.4.5 South Korea
    • 8.4.6 Rest of Asia Pacific
  • 8.5 Latin America
    • 8.5.1 Brazil
    • 8.5.2 Mexico
    • 8.5.3 Argentina
    • 8.5.4 Rest of Latin America
  • 8.6 Middle East & Africa
    • 8.6.1 Saudi Arabia
    • 8.6.2 South Africa
    • 8.6.3 UAE
    • 8.6.4 Rest of Middle East & Africa

Chapter 9 Company Profiles

  • 9.1 Medtronic plc
  • 9.2 Boston Scientific Corporation
  • 9.3 Abbott Laboratories
  • 9.4 BTL Corporate
  • 9.5 Zynex, Inc.
  • 9.6 HMS Medical Systems
  • 9.7 OMRON Corporation
  • 9.8 BioMedical Life Systems
  • 9.9 HASOMED GmbH
  • 9.10 Saluda Medical Pty Ltd
ºñ±³¸®½ºÆ®
0 °ÇÀÇ »óǰÀ» ¼±Åà Áß
»óǰ ºñ±³Çϱâ
Àüü»èÁ¦